Haemonetics Corporation operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haemonetics with three other
companies in this sector in UNITED STATES :
Accuray Inc
(2020
sales of $382.93 million
of which 56%
was Service),
Abiomed, Inc.
($840.88 million
of which 96%
was Impella product revenue), and
Cantel Medical Corp.
($1.02 billion
of which 46%
was Medical).
Sales Analysis.
Haemonetics reported sales of $988.48 million
for the
fiscal
year ending
March of 2020.
This
represents
an
increase of 2.2%
versus 2019, when the company's sales were $967.58 million.
This was the third consecutive year of growth at Haemonetics.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Haemonetics had sales
of $910.37 million.